Your browser doesn't support javascript.
loading
Combining venetoclax and azacytidine with T-cell bispecific antibodies for treatment of acute myeloid leukemia: a preclinical assessment.
Hänel, Gerulf; Schönle, Anne; Neumann, Anne-Sophie; Nixdorf, Daniel; Philipp, Nora; Sponheimer, Monika; Leutbecher, Alexandra; Emhardt, Alica-Joana; Magno, Giulia; Bücklein, Veit; Eckmann, Jan; Dunshee, Diana; Kramar, Vesna; Korfi, Koorosh; Colombetti, Sara; Umaña, Pablo; Klein, Christian; Subklewe, Marion.
Afiliación
  • Hänel G; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Schönle A; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.
  • Neumann AS; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Nixdorf D; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Philipp N; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.
  • Sponheimer M; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Leutbecher A; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.
  • Emhardt AJ; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Magno G; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.
  • Bücklein V; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Eckmann J; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.
  • Dunshee D; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Kramar V; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.
  • Korfi K; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Colombetti S; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Umaña P; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Klein C; Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany.
  • Subklewe M; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Penzberg, Germany.
Leukemia ; 38(2): 398-402, 2024 02.
Article en En | MEDLINE | ID: mdl-38212534
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Anticuerpos Biespecíficos Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Anticuerpos Biespecíficos Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido